How much funding has Savara raised?

Savara has raised $17.4M in total funding, most recently a Series A round.

Where is Savara headquartered?

Savara is headquartered in Austin, Texas, United States.

What industry is Savara in?

Savara operates in Biotech, Healthcare, pharmaceuticals.

Savara

IPO

Breathing new life into rare respiratory disease treatment

Public · Austin, United States · Founded 2008 · $17.4M raised

Biotech

Healthcare

pharmaceuticals

Headquarters: Austin, Texas
Employees: 51–200
Founded: 2008
Business Model: B2B
Website: savarapharma.com

Total Funding: $17.4M
Last Round: $1.4M Series AMar 2013
Rounds: 3
Type: Public

About

Savara Inc. (Nasdaq: SVRA) is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Its lead product candidate, molgramostim inhalation solution (MOLBREEVI), is an inhaled recombinant GM-CSF in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP), a rare lung disease causing progressive respiratory failure.

Summary

Savara is a Biotech company based in Austin, United States, founded in 2008. It has raised $17.4M in total across 3 rounds, most recently a $1.4M Series A round in Mar 2013.